Immunovant Inc

NASDAQ:IMVT   4:00:00 PM EDT
18.66
-0.34 (-1.79%)
6:13:46 PM EDT: $18.70 +0.04 (+0.21%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Immunovant Inc Stock, NASDAQ:IMVT

320 West 37th Street, 6th floor, New York, New York 10018
United States of America
Phone: +1.917.580.3099
Number of Employees: 124
http://www.immunovant.com

Description

Immunovant, Inc. is a clinical-stage biopharmaceutical company. The firm focuses on enabling normal lives for patients with autoimmune diseases. It is developing a novel, fully human monoclonal antibody IMVT-1401 that selectively binds to and inhibits the neonatal fragment crystallizable receptor. The company was founded in 2018 and is headquartered in New York, NY.